Nipro Corporation (8086) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Nipro Corporation (8086:JPX), powered by AI.

Current Price
¥1,477
P/E Ratio
47.1
Market Cap
240.8B
Sector
Healthcare
What is the Nipro Corporation stock price forecast?

Nipro Corporation is currently trading at ¥1,477. View real-time AI analysis on Alpha Lenz.

What is Nipro Corporation insider trading activity?

View the latest insider trading data for Nipro Corporation on Alpha Lenz.

What is Nipro Corporation's P/E ratio?

Nipro Corporation's P/E ratio is 47.1.

Nipro Corporation

¥1.48K
JPX8086
Ask about Nipro Corporation's future dividend policy...
Alpha Chat Insight

Nipro Corporation trades at a P/E of 47.1 (premium valuation) with modest ROE of 2.1%.

Ask for details

Company Overview

Nipro Corporation is a diversified healthcare company that plays a vital role in the medical and pharmaceutical industries worldwide. Primarily focused on the development and distribution of medical devices, pharmaceuticals, and pharmaceutical packaging, Nipro serves as a critical supplier for hospitals, clinics, and research institutions. The company's medical device segment includes dialysis products, injection and infusion systems, and cardiovascular equipment, underscoring its significance in life-saving healthcare technologies. Additionally, Nipro manufactures pharmaceutical products such as generic drugs, which contribute to cost-effective healthcare solutions. In the pharmaceutical packaging domain, the company offers diverse options for storage and safe consumption of medications, affecting logistics and safety across the pharmaceutical industry. Headquartered in Osaka, Japan, Nipro's extensive product portfolio and global distribution network emphasize its commitment to advancing healthcare outcomes and improving patient care efficiency. By supporting crucial medical infrastructure, Nipro Corporation holds a fundamental position in ensuring the operational effectiveness of healthcare providers around the world.

SectorHealthcare
IndustryMedical Instruments & Supplies
Employees39,168

Company Statistics

(FY 2025)

Profile

Market Cap¥240.81B
Revenue¥644.59B
Shares Out0.00
Employees39,168

Margins

Gross29.61%
EBITDA13.08%
Operating4.13%
Pre-Tax2.96%
Net1.03%

Valuation

P/E47.09
P/B0.95
EV/Sales0.37
EV/EBITDA9.85
P/FCF3.52

Growth (CAGR)

Rev 3Yr9.22%
Rev 5Yr7.81%
Op Inc 3Yr3.65%
Op Inc 5Yr0.13%
Net Inc 3Yr-23.79%
Net Inc 5YrN/A

Returns

ROA0.58%
ROE2.11%
ROIC2.36%

Financial Health

Cash & Cash Equivalents¥106.67B
Net Debt¥752.28B
Debt/Equity275.64%
Interest CovN/A
Ask Alpha Chat

Frequently Asked Questions

Alpha Lenz
Singapore
CEO: Kyungtae Kim | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2025 Treasurer. All rights reserved.
Nipro Corporation (Healthcare) Stock Forecast & Analysis ¥1,477 | Alpha Lenz